Author Correction: Cobrotoxin could be an effective therapeutic for COVID-19

Fang Lin,Paul F. Reid,Zheng-hong Qin

DOI: https://doi.org/10.1038/s41401-020-00533-z

IF: 7.169

2020-09-18

Acta Pharmacologica Sinica

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

pharmacology & pharmacy,chemistry, multidisciplinary

What problem does this paper attempt to address?

Corrigendum: COVIEdb: A Database for Potential Immune Epitopes of Coronaviruses.

Jingcheng Wu,Wenfan Chen,Jingjing Zhou,Wenyi Zhao,Yisheng Sun,Hanping Zhu,Pingping Yao,Shuqing Chen,Jianmin Jiang,Zhan Zhou

DOI: https://doi.org/10.3389/fphar.2020.646111

IF: 5.6

2021-01-01

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.572249.].
Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Pingping Ren,Luying Lu,Shasha Cai,Jianghua Chen,Weiqiang Lin,Fei Han

DOI: https://doi.org/10.3389/fimmu.2024.1513491

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.713540.].
Corrigendum: Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review

Zhi-Hua Yang,Bin Wang,Qian Ma,Lin Wang,Ya-Xin Lin,Hai-Feng Yan,Zi-Xuan Fan,Hao-Jia Chen,Zhao Ge,Feng Zhu,Hui-Jie Wang,Bao-Nan Zhang,Hai-Dong Sun,Li-Min Feng

DOI: https://doi.org/10.3389/fphar.2021.770125

IF: 5.6

2021-10-25

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.668407.].

pharmacology & pharmacy
Correction To: Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein–ACE2 interaction

ChangDong Lin,Yue Li,YueBin Zhang,ZhaoYuan Liu,Xia Mu,Chenjian Gu,Jing Liu,Yutang Li,GuoHui Li,JianFeng Chen

DOI: https://doi.org/10.1038/s41392-021-00643-y

IF: 39.3

2021-06-10

Signal Transduction and Targeted Therapy

Abstract:<p>Signal Transduction and Targeted Therapy, Published online: 10 June 2021; <a href="https://www.nature.com/articles/s41392-021-00643-y">doi:10.1038/s41392-021-00643-y</a></p>Correction To: Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein–ACE2 interaction

biochemistry & molecular biology,cell biology
Corrigendum: Scorpion Venom Heat-Resistant Peptide Attenuates Microglia Activation and Neuroinflammation

Xue-Fei Wu,Chun Li,Guang Yang,Ying-Zi Wang,Yan Peng,Dan-Dan Zhu,Ao-Ran Sui,Qiong Wu,Qi-Fa Li,Bin Wang,Na Li,Yue Zhang,Bi-Ying Ge,Jie Zhao,Shao Li

DOI: https://doi.org/10.3389/fphar.2021.791953

IF: 5.6

2021-11-26

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.704715.].

pharmacology & pharmacy
Corrigendum to "Atrase A, a P-III class metalloproteinase purified from cobra venom, exhibits potent anticoagulant activity by inhibiting coagulation pathway and activating the fibrinolytic system" [Heliyon Volume 10, Issue 10, 30 May 2024, Article e30969]

Xin-Jie Zhong,Cai-E Wang,Ya-Nan Li,Qi-Yun Zhang,Qian-Yun Sun

DOI: https://doi.org/10.1016/j.heliyon.2024.e33331

IF: 3.776

2024-06-27

Heliyon

Abstract:[This corrects the article DOI: 10.1016/j.heliyon.2024.e30969.].
Author Correction: Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing

Wen Wen,Wenru Su,Hao Tang,Wenqing Le,Xiaopeng Zhang,Yingfeng Zheng,Xiuxing Liu,Lihui Xie,Jianmin Li,Jinguo Ye,Liwei Dong,Xiuliang Cui,Yushan Miao,Depeng Wang,Jiantao Dong,Chuanle Xiao,Wei Chen,Hongyang Wang

DOI: https://doi.org/10.1038/s41421-020-00187-5

IF: 38.079

2020-06-20

Cell Discovery

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

cell biology
Corrigendum: Interferon-α2b Treatment for COVID-19

Qiong Zhou,Virginia Chen,Casey P. Shannon,Xiao-Shan Wei,Xuan Xiang,Xu Wang,Zi-Hao Wang,Scott J. Tebbutt,Tobias R. Kollmann,Eleanor N. Fish

DOI: https://doi.org/10.3389/fimmu.2020.615275

IF: 7.3

2020-10-27

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2020.01061.].

immunology
Corrigendum to: Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein

Pengfei Pei,Hongbo Qin,Jialin Chen,Fengli Wang,Chengzhi He,Shiting He,Bixia Hong,Ke Liu,Renzhong Qiao,Huahao Fan,Yigang Tong,Long Chen,Shi-Zhong Luo

DOI: https://doi.org/10.1093/bib/bbab298

IF: 9.5

2021-07-17

Briefings in Bioinformatics

Abstract:Upon the original publication of this article, two author names were incorrectly given as ``Ren zhong Qiao'' and ``Yi-gang Tong''. These should read: ``Renzhong Qiao'' and ``Yigang Tong''. As well as this, separating semi-colons were missing from the keywords. These errors have now been corrected online.

biochemical research methods,mathematical & computational biology
Corrigendum: Dopamine homeostasis imbalance and dopamine receptors-mediated AC/cAMP/PKA pathway activation are involved in aconitine-induced neurological impairment in zebrafish and SH-SY5Y cells

Jie Zhou,Cheng Peng,Qiuju Li,Xiaoyu Yan,Liang Yang,Mengting Li,Xiaoyu Cao,Xiaofang Xie,Dayi Chen,Chaolong Rao,Sizhou Huang,Fu Peng,Xiaoqi Pan

DOI: https://doi.org/10.3389/fphar.2023.1219561

IF: 5.6

2023-05-16

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.837810.].

pharmacology & pharmacy
Corrigendum: The immunomodulatory mechanism of acupuncture treatment for ischemic stroke: research progress, prospects, and future direction

Hongjun Kuang,Xinzhou Zhu,Huan Chen,Han Tang,Hong Zhao

DOI: https://doi.org/10.3389/fimmu.2024.1468179

2024-08-16

Abstract:[This corrects the article DOI: 10.3389/fimmu.2024.1319863.].
Corrigendum: Host factor interaction networks identified by integrative bioinformatics analysis reveals therapeutic implications in COPD patients with COVID-19

Wenjiang Zheng,Ting Wang,Peng Wu,Qian Yan,Chengxin Liu,Hui Wu,Shaofeng Zhan,Xiaohong Liu,Yong Jiang,Hongfa Zhuang

DOI: https://doi.org/10.3389/fphar.2023.1256022

IF: 5.6

2023-07-26

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.718874.].

pharmacology & pharmacy
Corrigendum: Therapy of spinal cord injury by folic acid polyethylene glycol amine-modified zeolitic imidazole framework-8 nanoparticles targeted activated M/Ms

Qi Li,Yue Guo,Chang Xu,Jiachen Sun,Fanzhuo Zeng,Sen Lin,Yajiang Yuan

DOI: https://doi.org/10.3389/fbioe.2023.1200532

IF: 5.7

2023-05-05

Frontiers in Bioengineering and Biotechnology

Abstract:[This corrects the article DOI: 10.3389/fbioe.2022.959324.].

multidisciplinary sciences
Correction: Discovery of novel non-peptidic and non-covalent small-molecule 3CL pro inhibitors as potential candidate for COVID-19 treatment

Zhidong Jiang,Bo Feng,Yumin Zhang,Tianqing Nie,Hong Liu,Jia Li,Haixia Su,Leike Zhang,Yi Zang,Yu Zhou

DOI: https://doi.org/10.1038/s41392-023-01665-4

IF: 39.3

2023-10-14

Signal Transduction and Targeted Therapy

Abstract:Signal Transduction and Targeted Therapy - Correction: Discovery of novel non-peptidic and non-covalent small-molecule 3CLpro inhibitors as potential candidate for COVID-19 treatment

biochemistry & molecular biology,cell biology
Corrigendum: The traditional Chinese medicine formula Jing Guan Fang for preventing SARS-CoV-2 infection: from clinical observation to basic research

Yueh-Hsin Ping,Hsin Yeh,Li-Wei Chu,Zhi-Hu Lin,Yin-Chieh Hsu,Lie-Chwen Lin,Chung-Hua Hsu,Shu-Ling Fu,Tung-Yi Lin

DOI: https://doi.org/10.3389/fphar.2023.1272615

IF: 5.6

2023-08-28

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.744439.].

pharmacology & pharmacy
Corrigendum: Advancement in the Development of Therapeutics Against Zika Virus Infection

Kangchen Li,Qianting Ji,Shibo Jiang,Naru Zhang

DOI: https://doi.org/10.3389/fcimb.2022.1006226

IF: 6.073

2022-01-01

Frontiers in Cellular and Infection Microbiology

Abstract:[This corrects the article DOI: 10.3389/fcimb.2022.946957.].
Correction: Huynh et al. Spike Protein Impairs Mitochondrial Function in Human Cardiomyocytes: Mechanisms Underlying Cardiac Injury in COVID-19. Cells 2023, 12, 877

Tin Van Huynh,Lekha Rethi,Ting-Wei Lee,Satoshi Higa,Yu-Hsun Kao,Yi-Jen Chen

DOI: https://doi.org/10.3390/cells13221865

IF: 6

2024-11-13

Cells

Abstract:Cells, Vol. 13, Pages 1865: Correction: Huynh et al. Spike Protein Impairs Mitochondrial Function in Human Cardiomyocytes: Mechanisms Underlying Cardiac Injury in COVID-19. Cells 2023, 12, 877 Cells doi: 10.3390/cells13221865 Authors: Tin Van Huynh Lekha Rethi Ting-Wei Lee Satoshi Higa Yu-Hsun Kao Yi-Jen Chen There was an error in the original publication [...]

cell biology
Author Correction: Reversing a model of Parkinson’s disease with in situ converted nigral neurons

Hao Qian,Xinjiang Kang,Jing Hu,Dongyang Zhang,Zhengyu Liang,Fan Meng,Xuan Zhang,Yuanchao Xue,Roy Maimon,Steven F. Dowdy,Neal K. Devaraj,Zhuan Zhou,William C. Mobley,Don W. Cleveland,Xiang-Dong Fu

DOI: https://doi.org/10.1038/s41586-020-2583-3

IF: 64.8

2020-07-29

Nature

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

multidisciplinary sciences
Author Correction: Anti-inflammatory effect of afatinib (an EGFR-TKI) on OGD-induced neuroinflammation

Yen-Ju Chen,Chia-Chi Hsu,Young-Ji Shiao,Hsiang-Tsui Wang,Yu-Li Lo,A. M. Y. Lin

DOI: https://doi.org/10.1038/s41598-020-80901-1

IF: 4.6

2021-01-25

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

multidisciplinary sciences
Corrigendum: Oseltamivir Improved Thrombocytopenia During Veno-Arterial Extracorporeal Membrane Oxygenation in Adults With Refractory Cardiac Failure: A Single-Center Retrospective Real-World Study

Yuan Li,Lin Wang,Jianning Zhang,Hui Han,Han Liu,Chaoyang Li,Haipeng Guo,Yuguo Chen,Xiaomei Chen

DOI: https://doi.org/10.3389/fcvm.2021.784904

IF: 3.6

2021-10-29

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2021.645867.].

cardiac & cardiovascular systems

Author Correction: Cobrotoxin could be an effective therapeutic for COVID-19

Corrigendum: COVIEdb: A Database for Potential Immune Epitopes of Coronaviruses.

Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Corrigendum: Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review

Correction To: Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein–ACE2 interaction

Corrigendum: Scorpion Venom Heat-Resistant Peptide Attenuates Microglia Activation and Neuroinflammation

Corrigendum to "Atrase A, a P-III class metalloproteinase purified from cobra venom, exhibits potent anticoagulant activity by inhibiting coagulation pathway and activating the fibrinolytic system" [Heliyon Volume 10, Issue 10, 30 May 2024, Article e30969]

Author Correction: Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing

Corrigendum: Interferon-α2b Treatment for COVID-19

Corrigendum to: Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein

Corrigendum: Dopamine homeostasis imbalance and dopamine receptors-mediated AC/cAMP/PKA pathway activation are involved in aconitine-induced neurological impairment in zebrafish and SH-SY5Y cells

Corrigendum: The immunomodulatory mechanism of acupuncture treatment for ischemic stroke: research progress, prospects, and future direction

Corrigendum: Host factor interaction networks identified by integrative bioinformatics analysis reveals therapeutic implications in COPD patients with COVID-19

Corrigendum: Therapy of spinal cord injury by folic acid polyethylene glycol amine-modified zeolitic imidazole framework-8 nanoparticles targeted activated M/Ms

Correction: Discovery of novel non-peptidic and non-covalent small-molecule 3CL pro inhibitors as potential candidate for COVID-19 treatment

Corrigendum: The traditional Chinese medicine formula Jing Guan Fang for preventing SARS-CoV-2 infection: from clinical observation to basic research

Corrigendum: Advancement in the Development of Therapeutics Against Zika Virus Infection

Correction: Huynh et al. Spike Protein Impairs Mitochondrial Function in Human Cardiomyocytes: Mechanisms Underlying Cardiac Injury in COVID-19. Cells 2023, 12, 877

Author Correction: Reversing a model of Parkinson’s disease with in situ converted nigral neurons

Author Correction: Anti-inflammatory effect of afatinib (an EGFR-TKI) on OGD-induced neuroinflammation

Corrigendum: Oseltamivir Improved Thrombocytopenia During Veno-Arterial Extracorporeal Membrane Oxygenation in Adults With Refractory Cardiac Failure: A Single-Center Retrospective Real-World Study